Study shows new weight-loss injection heading to Israel slows down the progression to

A new study by Eli Lilly, published on Tuesday night, showcases the remarkable efficacy of the drug Tirzepatide (also known as Mounjaro) in significantly reducing the risk of progression to type 2 diabetes among adults with prediabetes and…